Virco Mfg. (VIRC) Stock Forecast, Price & News

0 equities research analysts have issued 1-year target prices for Virco Mfg.'s shares. Their VIRC share price forecasts range from $8.00 to $8.00. On average, they predict the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 111.4% from the stock's current price.
View analysts price targets for VIRC or view top-rated stocks among Wall Street analysts.

Virco Mfg.'s stock was trading at $4.52 at the beginning of the year. Since then, VIRC shares have decreased by 16.3% and is now trading at $3.7850.
View the best growth stocks for 2023 here.

Virco Mfg. saw a drop in short interest in May. As of May 15th, there was short interest totaling 5,600 shares, a drop of 45.6% from the April 30th total of 10,300 shares. Based on an average daily trading volume, of 19,300 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the company's stock are short sold.
View Virco Mfg.'s Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, June 9th 2023.
View our VIRC earnings forecast.

Virco Mfg. Co. (NASDAQ:VIRC) posted its earnings results on Monday, December, 13th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by $0.25. The company had revenue of $57.33 million for the quarter, compared to analysts' expectations of $79.40 million. Virco Mfg. had a trailing twelve-month return on equity of 29.11% and a net margin of 7.16%.

8 employees have rated Virco Mfg. Chief Executive Officer Robert A. Virtue on Glassdoor.com. Robert A. Virtue has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Virco Mfg. investors own include Aldeyra Therapeutics (ALDX), SSR Mining (SSRM), Alimera Sciences (ALIM), Verizon Communications (VZ), AbbVie (ABBV), Acasti Pharma (ACST), Allena Pharmaceuticals (ALNA), Athersys (ATHX) and BioCryst Pharmaceuticals (BCRX).

Virco Mfg. trades on the NASDAQ under the ticker symbol "VIRC."

Virco Mfg.'s stock is owned by many different retail and institutional investors. Top institutional investors include D.A. Davidson & CO. (5.34%), Dimensional Fund Advisors LP (2.65%), Renaissance Technologies LLC (1.23%) and Wedbush Securities Inc. (0.28%). Insiders that own company stock include Agnieszka Winkler, Craig L Levra, Donald R Rudkin, Douglas A Virtue, Kathleen D Young and Robert A Virtue.
View institutional ownership trends.

Shares of VIRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VIRC stock can currently be purchased for approximately $3.79.

Virco Mfg. (NASDAQ:VIRC) has a market capitalization of $61.35 million and generates $231.06 million in revenue each year. The company earns $16.55 million in net income (profit) each year or $1.01 on an earnings per share basis.

The company employs 775 workers across the globe.

Virco Mfg.'s mailing address is 2027 Harpers Way, Torrance CA, 90501. The official website for the company is www.virco.com. The company can be reached via phone at (310) 533-0474 or via fax at 800-258-7367.